Literature DB >> 24493250

Sorafenib use in hepatocellular carcinoma: more questions than answers.

Ghassan K Abou-Alfa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24493250     DOI： 10.1002/hep.27044

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  14 in total

1.  Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals.

Authors:  Liang Shi; Hui Lin; Gonghui Li; Yin Sun; Jiliang Shen; Junjie Xu; Changyi Lin; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Cancer Lett       Date:  2016-01-19       Impact factor: 8.679

2.  Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.

Authors:  Zhexuan Wang; Enxin Wang; Wei Bai; Dongdong Xia; Rong Ding; Jiaping Li; Qiuhe Wang; Lei Liu; Junhui Sun; Wei Mu; Hui Zhao; Xingnan Pan; Guoliang Shao; Xiaoli Zhu; Guowen Yin; Haibin Shi; Jianbing Wu; Zhengyu Lin; Shufa Yang; Jueshi Liu; Wenhui Wang; Xu Zhu; Yong Lv; Jing Li; Hui Chen; Wenjun Wang; Kai Li; Xulong Yuan; Tanlei Yu; Jie Yuan; Xiaomei Li; Jing Niu; Zhanxin Yin; Jielai Xia; Daiming Fan; Guohong Han
Journal:  Liver Cancer       Date:  2020-02-19       Impact factor: 11.740

3.  Therapeutic Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Recurrence After Liver Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Zhao Li; Jie Gao; ShengMin Zheng; Yang Wang; Xiao Xiang; Qian Cheng; Jiye Zhu
Journal:  Turk J Gastroenterol       Date:  2021-01       Impact factor: 1.852

Review 4.  The immune system in hepatocellular carcinoma and potential new immunotherapeutic strategies.

Authors:  Gaetano Bertino; Shirin Demma; Annalisa Ardiri; Maria Proiti; Alessandra Mangia; Salvatore Gruttadauria; Adriana Toro; Isidoro Di Carlo; Giulia Malaguarnera; Nicoletta Bertino; Mariano Malaguarnera; Michele Malaguarnera
Journal:  Biomed Res Int       Date:  2015-03-29       Impact factor: 3.411

5.  Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study.

Authors:  Lin Zheng; Chen-Yang Guo; Cheng-Shi Chen; Jin-Cheng Xiao; Hong-Tao Hu; Hong-Tao Cheng; Deng-Wei Zong; Li Jiang; Hai-Liang Li
Journal:  Oncotarget       Date:  2017-06-29

6.  The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management.

Authors:  Luca Faloppi; Mario Scartozzi; Maristella Bianconi; Gianluca Svegliati Baroni; Pierluigi Toniutto; Riccardo Giampieri; Michela Del Prete; Samuele De Minicis; Davide Bitetto; Cristian Loretelli; Marco D'Anzeo; Antonio Benedetti; Stefano Cascinu
Journal:  BMC Cancer       Date:  2014-02-20       Impact factor: 4.430

Review 7.  Role of estrogen in hepatocellular carcinoma: is inflammation the key?

Authors:  Liang Shi; Yili Feng; Hui Lin; Rui Ma; Xiujun Cai
Journal:  J Transl Med       Date:  2014-04-08       Impact factor: 5.531

Review 8.  Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies.

Authors:  Gaetano Bertino; Shirin Demma; Annalisa Ardiri; Maria Proiti; Salvatore Gruttadauria; Adriana Toro; Giulia Malaguarnera; Nicoletta Bertino; Michele Malaguarnera; Mariano Malaguarnera; Isidoro Di Carlo
Journal:  Biomed Res Int       Date:  2014-06-25       Impact factor: 3.411

9.  pERK/pAkt phenotyping in circulating tumor cells as a biomarker for sorafenib efficacy in patients with advanced hepatocellular carcinoma.

Authors:  Jun Li; Lehua Shi; Xiaofeng Zhang; Bin Sun; Yefa Yang; Naijian Ge; Huiying Liu; Xia Yang; Lei Chen; Haihua Qian; Mengchao Wu; Zhengfeng Yin
Journal:  Oncotarget       Date:  2016-01-19

Review 10.  Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers.

Authors:  Francesca M Trovato; Joshua M Tognarelli; Mary Me Crossey; Daniela Catalano; Simon D Taylor-Robinson; Guglielmo M Trovato
Journal:  World J Hepatol       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.